CompletedNot Applicable

Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control

United States114 participantsStarted 2024-01-29

Plain-language summary

The suprazygomatic maxillary nerve (SZMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures. However, it has not been studied for patients undergoing tonsillectomy and adenoidectomy (T\&A) procedures. The goal of this study is to determine whether the SZMN block can be utilized to improve pain control and decrease morbidity in pediatric patients undergoing T\&A. An additional goal will be to determine whether the use of dexmedetomidine as a local anesthetic adjunct can prolong the analgesic effects of the SZMN block to cover the entire duration of pain experienced.

Who can participate

Age range6 Months – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Ages 6 months - 18 years * Give consent/parental consent to participate in study * Patients undergoing tonsillectomy and adenoidectomy Exclusion Criteria: * Participants who do not consent or have parental consent * Patients who require urgent/emergent intervention * Patients who undergo additional combined surgical procedures with separate incisions (in addition to the adenotonsillectomy) * Patients with known difficult airway, clinical hemodynamic instability, coagulopathy, chronic pain history, chronic pain medication use, and unrepaired congenital heart disease * Patients under age 6 months

What they're measuring

Postoperative Surgical Pain

Timeframe: Time Frame: 14 days after surgery

Postoperative Opioid Consumption

Timeframe: Time Frame: 14 days after surgery

Trial details

NCT IDNCT05208892

SponsorStanford University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

View on ClinicalTrials.gov More Postoperative Pain trials